B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 47.74 CNY -1.59%
Market Cap: 20B CNY
Have any thoughts about
Betta Pharmaceuticals Co Ltd?
Write Note

Betta Pharmaceuticals Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Betta Pharmaceuticals Co Ltd
Accounts Receivables Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
B
Betta Pharmaceuticals Co Ltd
SZSE:300558
Accounts Receivables
ÂĄ210.9m
CAGR 3-Years
13%
CAGR 5-Years
21%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accounts Receivables
ÂĄ3.2B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accounts Receivables
ÂĄ809.6m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
14%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accounts Receivables
ÂĄ6.2B
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accounts Receivables
ÂĄ10.1B
CAGR 3-Years
21%
CAGR 5-Years
36%
CAGR 10-Years
28%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accounts Receivables
ÂĄ98.4m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Betta Pharmaceuticals Co Ltd's Accounts Receivables?
Accounts Receivables
210.9m CNY

Based on the financial report for Jun 30, 2024, Betta Pharmaceuticals Co Ltd's Accounts Receivables amounts to 210.9m CNY.

What is Betta Pharmaceuticals Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
21%

Over the last year, the Accounts Receivables growth was -58%. The average annual Accounts Receivables growth rates for Betta Pharmaceuticals Co Ltd have been 13% over the past three years , 21% over the past five years .

Back to Top